NCT06448143View on ClinicalTrials.gov

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Ureter Injury

Interventions

DRUG

Indigotindisulfonate sodium 0.8% injection

Experimental contrast dye for diagnostic procedures, commonly used as a visualization aid in pelvic and abdominal surgeries, as well as for evaluating ureteral patency.

All Listed Sponsors

lead

Prove pharm

INDUSTRY